AZAnne M. Zimmer

Anne M. Zimmer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anne M. Zimmer has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Andreas Zimmer

    Laboratories of Genetics and Cellular and Molecular Regulation, National Institute of Mental Health, Bethesda, MD 20892

    3 shared publications
  • Tom I. Bonner

    Department of Anatomy and Neurobiology, University of Tennessee, College of Medicine, 855 Monroe Avenue, Memphis, TN 38163; and †Laboratory of Genetics, National Institute of Mental Health, Building 36, Room 3D-06, Bethesda, MD 20892

    2 shared publications
  • Andrea G. Hohmann

    Laboratories of Genetics and Cellular and Molecular Regulation, National Institute of Mental Health, Bethesda, MD 20892

    1 shared publication
  • Georgina Miller

    Veterinary Resources Program, National Institute for Research Resources; National Institutes of Health, Building 28A, Room 117, Bethesda, MD 20892, USA

    1 shared publication
  • Heidi Hahn

    Section on Genetics, National Institute of Mental Health, Bethesda, MD 20892, USA

    1 shared publication
  • Heinz Steiner

    Department of Anatomy and Neurobiology, University of Tennessee, College of Medicine, 855 Monroe Avenue, Memphis, TN 38163, USA

    1 shared publication

Latest Publications

  • Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice

    by Heinz Steiner, Tom I. Bonner, Anne M. Zimmer, Stephen T. Kitai

    The basal ganglia, a brain structure critical for sensorimotor and motivational aspects of behavior, contain very high levels of CB1 cannabinoid receptors. These receptors are activated by endogenous lipophilic ligands, and they are thought to mediate behavioral effects of cannabinoid drugs. To evaluate the role of the endogenous cannabinoid system in the regulation of basal ganglia pathways, we have investigated the effects of targeted deletion of CB1 receptors on gene expression of various neuropeptides and transmitter-related enzymes in basal ganglia neurons. Mice without CB1 receptors are extremely hypoactive in a test for exploratory behavior (open-field test), showing markedly reduced locomotion and rearing. These CB1 mutants display significantly increased levels of substance P, dynorphin, enkephalin, and GAD 67 mRNAs in neurons of the two output pathways of the striatum that project to the substantia nigra and the globus pallidus. Our findings demonstrate that elimination of CB1 receptors results in behavioral abnormalities and functional reorganization of the basal ganglia.


  • Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

    by Andreas Zimmer, Anne M. Zimmer, Andrea G. Hohmann, Miles Herkenham, Tom I. Bonner

    Δ 9 -Tetrahydrocannabinol (Δ 9 -THC), the major psychoactive ingredient in preparations of Cannabis sativa (marijuana, hashish), elicits central nervous system (CNS) responses, including cognitive alterations and euphoria. These responses account for the abuse potential of cannabis, while other effects such as analgesia suggest potential medicinal applications. To study the role of the major known target of cannabinoids in the CNS, the CB1 cannabinoid receptor, we have produced a mouse strain with a disrupted CB1 gene. CB1 knockout mice appeared healthy and fertile, but they had a significantly increased mortality rate. They also displayed reduced locomotor activity, increased ring catalepsy, and hypoalgesia in hotplate and formalin tests. Δ 9 -THC-induced ring-catalepsy, hypomobility, and hypothermia were completely absent in CB1 mutant mice. In contrast, we still found Δ 9 -THC-induced analgesia in the tail-flick test and other behavioral (licking of the abdomen) and physiological (diarrhea) responses after Δ 9 -THC administration. Thus, most, but not all, CNS effects of Δ 9 -THC are mediated by the CB1 receptor.


  • Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome

    by Heidi Hahn, Leszek Wojnowski, Anne M. Zimmer, Jennifer Hall, Georgina Miller, Andreas Zimmer

    Gorlin (or nevoid basal cell carcinoma) syndrome is characterized by a variety of clinical problems including generalized overgrowth of the body, cysts, developmental abnormalities of the skeleton and a predisposition to benign and malignant tumors1,2. The syndrome results from germline mutations of the human homolog of the drosophila segment polarity gene patched (ptc)3,4. Here we report that mice heterozygous for ptc develop many of the features characteristic of Corlin syndrome and that they exhibit a high incidence of rhabdomyosarcomas (RMS), the most common soft-tissue sarcoma in children5. The downstream signalling partner of ptc, glil, was overexpressed in all RMSs analyzed, indicating that abnormal signalling of the ptc-glil pathway may be common for the various tumors6,7 associated with the syndrome. igf2, implicated in the formation of RMSs8, was also overexpressed, suggesting cross-talk between the ptc and igf2 pathways in tumorigenesis. Developemental defects in Corlin syndrome resemble those induced by ionizing radiation9. We show that ptc heterozygous mice exhibit increased incidence of radiation-induced teratogenesis. This suggests a role for ptc in the response to ionizing radiation and provides a model for both the systemic (developmental) and stochastic (cancer) abnormalities observed in Gorlin syndrome.


  • Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene

    by Andreas Zimmer, Anne M. Zimmer, Judith Baffi, Ted Usdin, Kay Reynolds, Monika König, Miklós Palkovits, Éva Mezey

    The tachykinin neuropeptides, substance P and substance K, are produced in nociceptive primary sensory neurons and in many brain regions involved in pain signaling. However, the precise role and importance of these neuropeptides in pain responses has been debated. We now show that mice that cannot produce these peptides display no significant pain responses following formalin injection and have an increased pain threshold in the hotplate test. On the other hand, the mutant mice react normally in the tail flick assay and acetic acid-induced writhing tests. These results demonstrate that substance P and/or substance K have essential functions in specific responses to pain.